| Primary |
| Glaucoma |
61.7% |
| Hypertension |
8.3% |
| Cataract |
6.7% |
| Intraocular Pressure Increased |
6.7% |
| Arrhythmia |
1.7% |
| Blood Cholesterol Increased |
1.7% |
| Diabetes Prophylaxis |
1.7% |
| Feeling Of Relaxation |
1.7% |
| Gastric Disorder |
1.7% |
| Insomnia |
1.7% |
| Pain |
1.7% |
| Prostate Cancer |
1.7% |
| Retching |
1.7% |
| Thyroid Disorder |
1.7% |
|
| Ocular Hyperaemia |
13.0% |
| Wrong Drug Administered |
13.0% |
| Respiratory Failure |
8.7% |
| Toxic Skin Eruption |
8.7% |
| Gait Disturbance |
4.3% |
| Glaucoma |
4.3% |
| Infarction |
4.3% |
| Joint Lock |
4.3% |
| Medication Error |
4.3% |
| Nightmare |
4.3% |
| Off Label Use |
4.3% |
| Palpitations |
4.3% |
| Product Quality Issue |
4.3% |
| Surgery |
4.3% |
| Thrombosis |
4.3% |
| Visual Acuity Reduced |
4.3% |
| Visual Impairment |
4.3% |
|
| Secondary |
| Glaucoma |
55.8% |
| Drug Use For Unknown Indication |
7.1% |
| Intraocular Pressure Increased |
5.2% |
| Cataract |
3.9% |
| Developmental Glaucoma |
3.9% |
| Hypertension |
3.9% |
| Depression |
2.6% |
| Anxiety |
1.9% |
| Diabetes Mellitus |
1.9% |
| Osteoporosis |
1.9% |
| Product Used For Unknown Indication |
1.9% |
| Prophylaxis |
1.9% |
| Thyroid Disorder |
1.9% |
| Blood Cholesterol Increased |
1.3% |
| Gastric Disorder |
1.3% |
| Arrhythmia |
0.6% |
| Blood Cholesterol |
0.6% |
| Blood Disorder |
0.6% |
| Diabetes Mellitus Management |
0.6% |
| Dyspnoea |
0.6% |
|
| Glaucoma |
17.0% |
| Intraocular Pressure Increased |
14.9% |
| Visual Acuity Reduced |
10.6% |
| Liver Function Test Abnormal |
6.4% |
| Raynaud's Phenomenon |
6.4% |
| Visual Impairment |
6.4% |
| Ocular Hyperaemia |
4.3% |
| Pyrexia |
4.3% |
| Vision Blurred |
4.3% |
| Visual Field Defect |
4.3% |
| Coronary Artery Disease |
2.1% |
| Death |
2.1% |
| Dermatitis Contact |
2.1% |
| Eczema |
2.1% |
| Glaucoma Surgery |
2.1% |
| Humerus Fracture |
2.1% |
| Hypertension |
2.1% |
| Injection Site Reaction |
2.1% |
| Lip Swelling |
2.1% |
| Multi-organ Failure |
2.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
20.2% |
| Product Used For Unknown Indication |
18.3% |
| Hypertension |
12.8% |
| Glaucoma |
8.6% |
| Diabetes Mellitus |
6.2% |
| Nausea |
5.1% |
| Constipation |
3.5% |
| Pain |
3.1% |
| Prophylaxis |
3.1% |
| Depression |
2.3% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
2.3% |
| Dementia Alzheimer's Type |
1.9% |
| Bone Disorder |
1.6% |
| Colon Cancer |
1.6% |
| Dysphonia |
1.6% |
| Hypercholesterolaemia |
1.6% |
| Insomnia |
1.6% |
| Malnutrition |
1.6% |
| Ocular Hypertension |
1.6% |
| Polyuria |
1.6% |
|
| Tremor |
12.5% |
| Platelet Count Decreased |
10.0% |
| Vomiting |
10.0% |
| Visual Acuity Reduced |
7.5% |
| Cataract |
5.0% |
| Convulsion |
5.0% |
| Hypoxia |
5.0% |
| Lacrimation Increased |
5.0% |
| Lymphoedema |
5.0% |
| Pulmonary Embolism |
5.0% |
| Respiratory Distress |
5.0% |
| Skin Cancer |
5.0% |
| Agranulocytosis |
2.5% |
| Blindness Unilateral |
2.5% |
| Conjunctival Haemorrhage |
2.5% |
| Depression |
2.5% |
| Dermatitis |
2.5% |
| Diabetes Mellitus |
2.5% |
| Epilepsy |
2.5% |
| Faecaloma |
2.5% |
|
